Anthony Deboer
Director
Business & Management
Synaffix
Netherlands
Biography
Prior to joining Synaffix in 2014, Anthony served as the Associate Director of Business Development at Allozyne, a Seattle-based biotech, where he was focused on partnering efforts around pipeline programs and antibody-drug conjugate technology leading up to an acquisition by MedImmune. Previously, he studied in the laboratory of Dr. Irv Weissman at the Stanford Institute for Stem Cell Biology and Regenerative Medicine. Anthony is a published co-author in Nature and PNAS and holds a BSc in Biotechnology from Seattle Pacific University.
Research Interest
Business & Management
